Lloyds TSB Corporate Markets has provided £20m to Aesica Pharmaceuticals to support its continuing expansion through organic growth and acquisitions.
Pharmacy Business
Tuesday, 3 August 2010
Aesica raises £20m
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment